{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:26:41Z","timestamp":1771504001298,"version":"3.50.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ejpn.2008.04.009","type":"journal-article","created":{"date-parts":[[2008,6,27]],"date-time":"2008-06-27T09:05:57Z","timestamp":1214557557000},"page":"209-218","source":"Crossref","is-referenced-by-count":43,"title":["Childhood acute and chronic immune-mediated polyradiculoneuropathies"],"prefix":"10.1016","volume":"13","author":[{"given":"Malcolm","family":"Rabie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoram","family":"Nevo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2008.04.009_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.20076","article-title":"Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system","volume":"30","author":"Kieseier","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejpn.2008.04.009_bib2","first-page":"CD003280","article-title":"Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"4","author":"Hughes","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl.","key":"10.1016\/j.ejpn.2008.04.009_bib3","first-page":"ii9","article-title":"Management of inflammatory neuropathies","volume":"74","author":"Hadden","year":"2003","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.ejpn.2008.04.009_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1085-9489.2005.0010203.x","article-title":"Treatment of Guillain\u2013Barr\u00e9 syndrome and CIDP","volume":"10","author":"van Doorn","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.ejpn.2008.04.009_bib5","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain\u2013Barr\u00e9 syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2008.04.009_bib6","series-title":"Current pediatric therapy","first-page":"364","article-title":"Acute and chronic immune-mediated polyneuropathy","author":"Rabie","year":"2006"},{"key":"10.1016\/j.ejpn.2008.04.009_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/088307380001500308","article-title":"New concepts of Guillain\u2013Barr\u00e9 syndrome","volume":"15","author":"Asbury","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib8","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"issue":"Suppl.","key":"10.1016\/j.ejpn.2008.04.009_bib9","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"41","author":"Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1468-1331.2006.01278.x","volume":"13","author":"Hughes","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMcpc020031","article-title":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-2003. A nine-year-old girl with progressive weakness and areflexia","volume":"348","author":"Sander","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejpn.2008.04.009_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0960-8966(01)00286-3","article-title":"88th ENMC international workshop: childhood chronic inflammatory demyelinating polyneuropathy (including revised diagnostic criteria), Naarden, The Netherlands, December 8\u201310, 2000","volume":"12","author":"Nevo","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2008.04.009_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410390105","article-title":"Pathology of the motor\u2013sensory axonal Guillain\u2013Barr\u00e9 syndrome","volume":"39","author":"Griffin","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/mus.20520","article-title":"Electrophysiological subtypes and prognosis of childhood Guillain\u2013Barr\u00e9 syndrome in Japan","volume":"33","author":"Nagasawa","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejpn.2008.04.009_bib17","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2008.04.009_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0887-8994(02)00626-4","article-title":"Outcome of axonal and demyelinating forms of Guillain\u2013Barr\u00e9 syndrome in children","volume":"28","author":"Tekgul","year":"2003","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib19","first-page":"191","article-title":"Guillain\u2013Barr\u00e9 syndrome in children","volume":"19","author":"Sladky","year":"2004","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0887-8994(03)00403-X","article-title":"A clinical and electrophysiologic survey of childhood Guillain\u2013Barr\u00e9 syndrome","volume":"30","author":"Hung","year":"2004","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/1531-8249(199911)46:5<701::AID-ANA4>3.0.CO;2-7","article-title":"Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain\u2013Barr\u00e9 syndrome: a reappraisal","volume":"46","author":"Paradiso","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/adc.66.6.706","article-title":"Occurrence, clinical manifestations, and prognosis of Guillain\u2013Barr\u00e9 syndrome","volume":"66","author":"Rantala","year":"1991","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ejpn.2008.04.009_bib23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1212\/WNL.47.3.813","article-title":"Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain\u2013Barr\u00e9 syndrome","volume":"47","author":"Gorson","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1212\/01.wnl.0000265396.87983.bd","article-title":"Patterns of Guillain\u2013Barre syndrome in children. Results from a Mexican population","volume":"69","author":"Nachamkin","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/adc.74.4.281","article-title":"Natural history and treatment effects in Guillain\u2013Barr\u00e9 syndrome: a multicentre study","volume":"74","author":"Korinthenberg","year":"1996","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ejpn.2008.04.009_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2007-981686","article-title":"Clinical presentation and course of childhood Guillain\u2013Barr\u00e9 syndrome: a prospective multicentre study","volume":"38","author":"Korinthenberg","year":"2007","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ejpn.2008.04.009_bib27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.61.6.736","article-title":"Practice parameter: immunotherapy for Guillain\u2013Barr\u00e9 syndrome: report of the\u00a0Quality Standards Subcommittee of the American Academy of Neurology","volume":"61","author":"Hughes","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00365549509019016","article-title":"Intravenous immunoglobulin treatment in children with Guillain\u2013Barre syndrome","volume":"27","author":"G\u00fcrses","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ejpn.2008.04.009_bib29","first-page":"223","article-title":"Intravenous immunoglobulin in children with Guillain\u2013Barr\u00e9 syndrome","volume":"16","author":"Wang","year":"2001","journal-title":"J Appl Clin Pediatr"},{"key":"10.1016\/j.ejpn.2008.04.009_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1542\/peds.2004-1324","article-title":"Intravenously administered immunoglobulin in the treatment of childhood Guillain\u2013Barr\u00e9 syndrome: a randomized trial","volume":"116","author":"Korinthenberg","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpn.2008.04.009_bib31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1212\/01.WNL.0000153071.71335.E9","article-title":"Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain\u2013Barr\u00e9 syndrome","volume":"64","author":"Hiraga","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.33588\/rn.4202.2005009","article-title":"Unusual variants of Guillain\u2013Barr\u00e9 syndrome in infancy","volume":"42","author":"Buompadre","year":"2006","journal-title":"Rev Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ncl.2006.11.003","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"25","author":"Lewis","year":"2007","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ejpn.2008.04.009_bib34","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/archneur.1992.00530300044009","article-title":"Subacute idiopathic demyelinating polyradiculoneuropathy","volume":"49","author":"Hughes","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib35","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/01.WNL.0000096166.28131.4C","article-title":"Subacute inflammatory demyelinating polyneuropathy","volume":"61","author":"Oh","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib36","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1212\/01.WNL.0000162047.89440.B9","article-title":"Subacute inflammatory demyelinating polyneuropathy in children","volume":"64","author":"Rodriguez-Casero","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib37","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","article-title":"Intravenous immunoglobulin in autoimmune neuromuscular diseases","volume":"291","author":"Dalakas","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejpn.2008.04.009_bib38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1529-8027.2007.00153.x","article-title":"Axonal Guillain\u2013Barr\u00e9 syndrome: carbohydrate mimicry and pathophysiology","volume":"12","author":"Yuki","year":"2007","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.ejpn.2008.04.009_bib39","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib40","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain\u2013Barr\u00e9 syndrome","volume":"56","author":"Hadden","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1212\/WNL.57.5.774","article-title":"CSF filtration is an effective treatment of Guillain\u2013Barr\u00e9 syndrome: a randomized clinical trial","volume":"57","author":"Wollinsky","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/adc.2006.098061","article-title":"Prospective study on anti-ganglioside antibodies in childhood Guillain\u2013Barr\u00e9 syndrome","volume":"92","author":"Schessl","year":"2007","journal-title":"Arch Dis Child"},{"issue":"Suppl.","key":"10.1016\/j.ejpn.2008.04.009_bib43","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1086\/513784","article-title":"Acute immune polyneuropathies: correlations of serum antibodies to Campylobacter jejuni and Helicobacter pylori with anti-GM1 antibodies and clinical patterns of disease","volume":"176","author":"Nevo","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejpn.2008.04.009_bib44","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/adc.76.6.526","article-title":"Campylobacter 0:41 isolation in Guillain\u2013Barr\u00e9 syndrome","volume":"76","author":"Goddard","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ejpn.2008.04.009_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1090-3798(98)80016-0","article-title":"Childhood chronic inflammatory demyelinating polyneuropathy","volume":"2","author":"Nevo","year":"1998","journal-title":"Europ J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1085-9489.2005.0010207.x","article-title":"Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"10","author":"Allen","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.ejpn.2008.04.009_bib47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0140-6736(91)90606-P","article-title":"Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China","volume":"338","author":"McKhann","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2008.04.009_bib48","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.880150415","article-title":"Guillain\u2013Barr\u00e9 syndrome in children: clinical course, electrodiagnosis, and prognosis","volume":"15","author":"Bradshaw","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejpn.2008.04.009_bib49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1440-1754.2005.00602.x","article-title":"Guillain\u2013Barr\u00e9 syndrome in childhood","volume":"41","author":"Ryan","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.ejpn.2008.04.009_bib50","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/088307380101600708","article-title":"Pseudomeningoencephalitic presentation of pediatric Guillain\u2013Barr\u00e9 syndrome","volume":"16","author":"Bradshaw","year":"2001","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib51","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00431-006-0140-1","article-title":"Infections and vaccinations preceding childhood Guillain\u2013Barr\u00e9 syndrome: a prospective study","volume":"165","author":"Schessl","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ejpn.2008.04.009_bib52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/JCM.43.1.335-339.2005","article-title":"Epidemiology of Campylobacter jejuni isolated from patients with Guillain\u2013Barr\u00e9 and Fisher syndromes in Japan","volume":"43","author":"Takahashi","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib53","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2006.05.018","article-title":"Susceptibility to Guillain\u2013Barr\u00e9 syndrome is associated to polymorphisms of CD1 genes","volume":"177","author":"Caporale","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib54","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1034\/j.1600-0455.2003.00023.x","article-title":"Childhood Guillain\u2013Barr\u00e9 syndrome. MR imaging in diagnosis and follow-up","volume":"44","author":"Co\u015fkun","year":"2003","journal-title":"Acta Radiol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib55","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archneur.62.8.1194","article-title":"Supportive care for patients with Guillain\u2013Barre syndrome","volume":"62","author":"Hughes","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0887-8994(95)00189-1","article-title":"Risk factors of respiratory failure in children with Guillain\u2013Barr\u00e9 syndrome","volume":"13","author":"Rantala","year":"1995","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib57","first-page":"CD005452","article-title":"Gabapentin for acute and chronic pain","volume":"3","author":"Wiffen","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejpn.2008.04.009_bib58","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain\u2013Barr\u00e9 syndrome","volume":"326","author":"van der Mech\u00e9","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejpn.2008.04.009_bib59","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1212\/01.WNL.0000129917.28461.0C","article-title":"Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration","volume":"62","author":"Nishimoto","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.410280112","article-title":"The role of plasmapheresis in childhood Guillain\u2013Barr\u00e9 syndrome","volume":"28","author":"Epstein","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib61","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1212\/WNL.41.12.1928","article-title":"Plasmapheresis in children with Guillain\u2013Barr\u00e9 syndrome","volume":"41","author":"Lamont","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0887-8994(90)90073-A","article-title":"Plasmapheresis with acute inflammatory polyneuropathy","volume":"6","author":"Khatri","year":"1990","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0887-8994(93)90004-V","article-title":"Guillain\u2013Barr\u00e9 syndrome in childhood: natural course and efficacy of plasmapheresis","volume":"9","author":"Jansen","year":"1993","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib64","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/08830738030180110501","article-title":"Ten-year prospective study (clinical spectrum) of childhood Guillain\u2013Barr\u00e9 syndrome in the Arabian peninsula: comparison of outcome in patients in the pre- and post-intravenous immunoglobulin eras","volume":"18","author":"Koul","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1542\/peds.2005-1022","article-title":"Intravenous immunoglobulin in the treatment of childhood Guillain\u2013Barr\u00e9 Syndrome: a randomized trial","volume":"116","author":"DiMario","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpn.2008.04.009_bib66","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12098-007-0122-y","article-title":"Exchange transfusion as an alternative therapy for recurrent severe Guillain\u2013Barre syndrome","volume":"74","author":"Baranwal","year":"2007","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.ejpn.2008.04.009_bib67","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1067\/mpd.2003.115","article-title":"Long-term outcome in children with Guillain\u2013Barr\u00e9 syndrome","volume":"142","author":"Vajsar","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejpn.2008.04.009_bib68","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/088307380101600703","article-title":"Childhood Guillain\u2013Barr\u00e9 syndrome: clinical and electrophysiologic features predictive of outcome","volume":"16","author":"Ammache","year":"2001","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib69","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/09638280701240326","article-title":"Motor recovery after Guillain\u2013Barr\u00e9 syndrome in childhood","volume":"29","author":"Ortiz-Corredor","year":"2007","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.ejpn.2008.04.009_bib70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1212\/WNL.47.1.98","article-title":"Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up","volume":"47","author":"Nevo","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0960-8966(02)00214-6","article-title":"Childhood chronic inflammatory demyelinating polyneuropathy with central nervous system demyelination resembling multiple sclerosis","volume":"13","author":"Rodriguez-Casero","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2008.04.009_bib72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pediatrneurol.2006.09.012","article-title":"Evolution and treatment of childhood chronic inflammatory polyneuropathy","volume":"36","author":"Rossignol","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib73","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s004150170093","article-title":"Pure motor chronic inflammatory demyelinating polyneuropathy","volume":"248","author":"Sabatelli","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib74","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/(SICI)1097-4598(199708)20:8<1008::AID-MUS11>3.0.CO;2-R","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults","volume":"20","author":"Simmons","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejpn.2008.04.009_bib75","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0887-8994(00)00237-X","article-title":"Chronic inflammatory demyelinating polyneuropathy in childhood","volume":"24","author":"Connolly","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib76","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0960-8966(00)00119-X","article-title":"Childhood chronic inflammatory demyelinating polyneuropathy: clinical course long-term outcome","volume":"10","author":"Ryan","year":"2000","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2008.04.009_bib77","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-510X(97)00216-5","article-title":"Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood","volume":"154","author":"Hattori","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ejpn.2008.04.009_bib78","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nmd.2006.02.008","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"16","author":"Said","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejpn.2008.04.009_bib79","first-page":"621","article-title":"Chronic inflammatory polyradiculoneuropathy","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejpn.2008.04.009_bib80","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2007-973489","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in children and their response to treatment","volume":"30","author":"Korinthenberg","year":"1999","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ejpn.2008.04.009_bib81","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1569::AID-MUS12>3.0.CO;2-W","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults","volume":"20","author":"Simmons","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejpn.2008.04.009_bib82","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0887-8994(03)00222-4","article-title":"Progressive muscle weakness after high-dose steroids in two children with CIDP","volume":"29","author":"Rostasy","year":"2003","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib83","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archneur.62.2.249","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone","volume":"62","author":"Lopate","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib84","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","article-title":"Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2008.04.009_bib85","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1212\/WNL.62.1.155","article-title":"Rapid resolution of quadriplegic CIDP by combined plasmapheresis and IVIg","volume":"62","author":"Walk","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib86","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1212\/WNL.45.8.1628","article-title":"The restoration of IVIg efficacy by plasma exchange in CIDP","volume":"45","author":"Berger","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib87","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jnnp.2005.074781","article-title":"Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate","volume":"77","author":"Fialho","year":"2006","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.ejpn.2008.04.009_bib88","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.pediatrneurol.2005.05.015","article-title":"Cyclosporine in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"33","author":"Visudtibhan","year":"2005","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib89","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jocn.2005.09.008","article-title":"Rituximab therapy in chronic inflammatory demyelinating polyradiculoneuropathy with anti-SGPG IgM antibody","volume":"13","author":"Gono","year":"2006","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ejpn.2008.04.009_bib90","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2007.02.027","article-title":"Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus","volume":"256","author":"M\u00fcnch","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ejpn.2008.04.009_bib91","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/jnnp.2005.076869","article-title":"Remission of chronic inflammatory demyelinating polyneuropathy after Alemtuzumab (Campath 1H)","volume":"77","author":"Hirst","year":"2006","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.ejpn.2008.04.009_bib92","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF00919601","article-title":"Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"242","author":"Choudhary","year":"1995","journal-title":"J Neurol"},{"key":"10.1016\/j.ejpn.2008.04.009_bib93","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/WNL.60.8_suppl_3.S23","article-title":"Interferon beta-1a as an investigational treatment for CIDP","volume":"60","author":"Vallat","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.04.009_bib94","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1212\/01.WNL.0000064163.94122.EB","article-title":"Contrasting effects of IFNbeta and IVIG in children with central and peripheral demyelination","volume":"60","author":"Pirko","year":"2003","journal-title":"Neurology"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379808000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379808000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T21:43:23Z","timestamp":1738273403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379808000998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1090379808000998"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2008.04.009","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}